GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma

GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma

ObjectivePancreatic ductal adenocarcinoma (PDAC) is a highly malignant neoplasm with rising incidence worldwide. Gremlin 1 (GREM1), a regulator of bone morphogenetic protein (BMP) signaling, fine-tunes extensive biological processes, including organ morphology, cellular metabolism, and multiple path...

Full description

Bibliographic Details
Main Authors:	Sen Yang, Yalu Zhang, Yuze Hua, Ming Cui, Mengyi Wang, Junyi Gao, Qiaofei Liu, Quan Liao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Oncology
Subjects:	gremlin 1 (GREM1) pancreatic adenocarcinoma (PDAC) tumor microenvironment diagnosis marker
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.968610/full

Similar Items

Knockdown of LRRN1 inhibits malignant phenotypes through the regulation of HIF-1α/Notch pathway in pancreatic ductal adenocarcinoma
by: Yalu Zhang, et al.
Published: (2021-12-01)

Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo
by: Kimberley C. Clark, et al.
Published: (2020-08-01)

Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma
by: Yalu Zhang, et al.
Published: (2022-01-01)

Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
by: Benjamin M. MacCurtain, et al.
Published: (2021-06-01)

Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma
by: Declan McDonnell, et al.
Published: (2023-12-01)

Oral mycobiota and pancreatic ductal adenocarcinoma
by: Ailin Wei, et al.
Published: (2022-12-01)

Association Between Plasma Grem1 and Peritoneal Permeability Alterations in Dialysis Patients
by: Cihan Uysal, et al.
Published: (2024-02-01)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
by: Natalia Michalak, et al.
Published: (2023-06-01)

Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies
by: Songyu Guo, et al.
Published: (2024-03-01)

Sonic Hedgehog Ligand: A Role in Formation of a Mesenchymal Niche in Human Pancreatic Ductal Adenocarcinoma
by: Francesca Saini, et al.
Published: (2019-05-01)

The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma
by: Sona Ciernikova, et al.
Published: (2020-12-01)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
by: Michael Karl Melzer, et al.
Published: (2020-05-01)

Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
by: Chengru Yang, et al.
Published: (2024-01-01)

Demethyleneberberine Alleviates Pulmonary Fibrosis through Disruption of USP11 Deubiquitinating GREM1
by: Chuang Ge, et al.
Published: (2024-02-01)

Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
by: Yan Li, et al.
Published: (2022-01-01)

Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
by: Maarten F. Bijlsma, et al.
Published: (2022-04-01)

Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
by: Vida Karimnia, et al.
Published: (2021-08-01)

Nicotine exacerbates diabetic nephropathy through upregulation of Grem1 expression
by: Jianning Chen, et al.
Published: (2023-07-01)

Elevated Glycated Haemoglobin (HbA1c) Is Associated with an Increased Risk of Pancreatic Ductal Adenocarcinoma: A UK Biobank Cohort Study
by: Declan McDonnell, et al.
Published: (2023-08-01)

The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma
by: Alexander A. Lekan, et al.
Published: (2024-01-01)

Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma
by: Yan Gong, et al.
Published: (2023-07-01)

Metabolism remodeling in pancreatic ductal adenocarcinoma
by: Jin-Tao Li, et al.
Published: (2019-11-01)

Pancreatic stromal Gremlin 1 expression during pancreatic tumorigenesis
by: Joy M. Davis, et al.
Published: (2022-01-01)

Glutathione S-Transferase pi-1 Knockdown Reduces Pancreatic Ductal Adenocarcinoma Growth by Activating Oxidative Stress Response Pathways
by: Rahul R. Singh, et al.
Published: (2020-06-01)

High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
by: Dong-jin Wu, et al.
Published: (2018-10-01)

Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review
by: Antonella Argentiero, et al.
Published: (2019-10-01)

Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study
by: Karolina Skubisz, et al.
Published: (2023-06-01)

Knockdown of circRNA_0007534 suppresses the tumorigenesis of cervical cancer via miR-206/GREM1 axis
by: Qiang Sun, et al.
Published: (2021-01-01)

Transient Receptor Potential Ankyrin 1 (TRPA1) Modulation by 4-Hydroxynonenal (4-HNE) in Pancreatic Adenocarcinoma Cell Lines: Putative Roles for Therapies
by: Florentina Piciu, et al.
Published: (2024-03-01)

Expression of sorting nexin 1 in pancreatic ductal adenocarcinoma and its mechanism in promoting PDAC progress
by: PAN Hong, et al.
Published: (2023-03-01)

A rare case of giant panda cancer: Pancreatic ductal adenocarcinoma
by: Yunsheng Wang, et al.
Published: (2022-12-01)

Prognostic Nutritional Index after Chemoradiotherapy Was the Strongest Prognostic Predictor among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients
by: Ken Ichikawa, et al.
Published: (2019-04-01)

Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas
by: Iram Siddiqui, et al.
Published: (2022-08-01)

GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients
by: Ulrike Neckmann, et al.
Published: (2019-11-01)

Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures
by: Lukas M. Braun, et al.
Published: (2020-06-01)

Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model
by: Kavita Mallya, et al.
Published: (2020-09-01)

Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics
by: Hideaki Ijichi
Published: (2022-10-01)

Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
by: Min Ren, et al.
Published: (2023-08-01)

Advances in Pancreatic Ductal Adenocarcinoma Treatment
by: Eric M. Anderson, et al.
Published: (2021-11-01)

GREM1 is a potential biomarker for the progression and prognosis of bladder cancer
by: Peng-cheng Jiang, et al.
Published: (2023-08-01)